Inflammation News and Research

RSS

Medtronic named 2010 MDEA winner for excellence in medical device design

Medtronic announced today that the company was named a 2010 Medical Device Excellence Award winner for excellence in medical device design for its Hydrodebrider System, manufactured by the company's Ear Nose and Throat business unit.

9 Apr 2010

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.

9 Apr 2010

More public-private partnerships crucial for success of Italian pharmaceutical industry

The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3).

9 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

Combination telaprevir treatment beneficial for retreatment of hepatitis C

A study co-authored by a Saint Louis University researcher found telaprevir, a protease inhibitor, combined with standard hepatitis C treatment, cures a significantly higher number of difficult-to-treat patients than standard treatment alone. The findings were published in the April issue of the New England Journal of Medicine.

9 Apr 2010

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.

9 Apr 2010

Role of beta defensins in development of chronic inflammatory response in the brain

Researchers at the Case Western Reserve University School of Dental Medicine and School of Medicine will look for evidence within the brain for human beta defensin peptide function-proteins important to the peripheral body's natural defense system against infection from the outside environment.

8 Apr 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.

8 Apr 2010

Aerocrine AB experiences low first-quarter sales development

Aerocrine AB today announced that its first quarter sales development has been below expectations. Revenues are estimated to reach approximately 18 MSEK compared to 26,9 MSEK previous year.

7 Apr 2010

Measure of blood flow in lungs could help identify smokers at risk of emphysema

Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study.

7 Apr 2010

Update on Aerocrine AB's patent infringement cases against Apieron

Aerocrine AB today announced that its patent infringement cases in the U.S. and Europe against Apieron Inc., Menlo Park, USA will be stayed as a result of Apieron filing for Chapter 7 bankruptcy.

7 Apr 2010

Anthera Pharmaceuticals announces closing of underwriters' exercise of over-allotment option

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the closing of the underwriters' exercise of their over-allotment option to purchase an additional 604,492 shares of Anthera's common stock, at a price of $7.00 per share.

7 Apr 2010

Study: Carbon nanotubes degraded by MPO enzyme induce less inflammation

A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme - myeloperoxidase (MPO) - found in white blood cells.

6 Apr 2010

Dalfampridine drug for multiple sclerosis now available in the U.S.

A drug whose clinical benefit in treating multiple sclerosis was discovered at Rush University Medical Center was approved by the Food and Drug Administration on January 22 and is now available in the U.S.

6 Apr 2010

Scientists show carbon nanotubes can be broken down by MPO

A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme - myeloperoxidase - found in white blood cells. Their discoveries are presented in Nature Nanotechnology and contradict what was previously believed, that carbon nanotubes are not broken down in the body or in nature.

5 Apr 2010

Is relief round the corner for multiple sclerosis patients in the form of bee stings?

A recent development can raise the hopes of many sufferers of Multiple Sclerosis (MS) – a dreaded, debilitating, fatal nerve disorder. Charity worker Sami Chugg, 45, claims to have overcome her condition after being stung by bees.

5 Apr 2010

Inflammation has a role to play in premature births and brain injury: Sahlgrenska Academy thesis

Researchers have gone some way to explaining what happens during premature births and how brain injury develops in premature babies. New findings show that inflammation in both the amniotic fluid and the baby's brain has a role to play, reveals a thesis from the Sahlgrenska Academy.

5 Apr 2010

UEA scientists discover group of molecules that can help fight spread of cancer

A team of scientists led by the University of East Anglia has discovered a brand new group of molecules which could help fight the spread of cancer and other diseases.

5 Apr 2010

Clinical utility and pharmacological action of MN-166 in treatment of MS

MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported that this week's issue of Neurology includes two articles related to the potential clinical utility and unique pharmacological action of MN-166 in treating multiple sclerosis (MS).

3 Apr 2010

Germplasm accessions of St. John's wort screened for biologically active compounds

A unique collection of St. John's wort (Hypericum) curated by Agricultural Research Service (ARS) scientists in Ames, Iowa, is providing university collaborators with genetically diverse, well-documented sources of this herb to use in studies examining its medicinal potential.

3 Apr 2010

Inflammation News and Research

Medtronic named 2010 MDEA winner for excellence in medical device design

Gamma-tocotrienol kills prostate tumour cells in animal model studies

More public-private partnerships crucial for success of Italian pharmaceutical industry

Tβ4 therapy for ocular disorders closer to reality

Combination telaprevir treatment beneficial for retreatment of hepatitis C

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Role of beta defensins in development of chronic inflammatory response in the brain

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Aerocrine AB experiences low first-quarter sales development

Measure of blood flow in lungs could help identify smokers at risk of emphysema

Update on Aerocrine AB's patent infringement cases against Apieron

Anthera Pharmaceuticals announces closing of underwriters' exercise of over-allotment option

Study: Carbon nanotubes degraded by MPO enzyme induce less inflammation

Dalfampridine drug for multiple sclerosis now available in the U.S.

Scientists show carbon nanotubes can be broken down by MPO

Is relief round the corner for multiple sclerosis patients in the form of bee stings?

Inflammation has a role to play in premature births and brain injury: Sahlgrenska Academy thesis

UEA scientists discover group of molecules that can help fight spread of cancer

Clinical utility and pharmacological action of MN-166 in treatment of MS

Germplasm accessions of St. John's wort screened for biologically active compounds

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News